Aldeyra Therapeutics, Inc.
COMBINATION TREATMENT OF OCULAR INFLAMMATORY DISORDERS AND DISEASES
Last updated:
Abstract:
The present disclosure provides a combination of a fused bicyclic amine compound and an anti-inflammatory agent for treating ocular inflammatory disorders and diseases. Further provided are pharmaceutical compositions of the compound and the anti-inflammatory agent.
Status:
Application
Type:
Utility
Filling date:
23 Sep 2021
Issue date:
16 Jun 2022